Core Insights - CareCloud resumed dividends on preferred shares in 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 to address arrearages [1] - The company converted approximately 80% of Series A preferred shares into common stock in 2025, eliminating over $7 million in annual dividend obligations [1] Financial Performance - Non-GAAP free cash flow was $20.5 million in 2025, a 55% increase from $13.2 million in 2024, indicating improved financial flexibility [2] - GAAP operating cash flow reached $28.6 million in 2025, up 38% year over year, with $8.7 million generated in Q4, a 66% increase [3] - Adjusted EBITDA for the full year was $27.5 million, representing a 23% margin, and increased 15% from $24.1 million in 2024 [4] - GAAP net income for 2025 was $10.8 million, up over 37% year over year, marking the first full year of positive EPS since the 2014 IPO [6] Revenue Growth - Full-year revenue for 2025 was $120.5 million, up nearly 9% year over year, with Q4 revenue at $34.4 million, a nearly 22% increase from the prior year [7] - CareCloud raised revenue guidance twice in 2025 and exceeded its final target [7] Strategic Acquisitions - CareCloud completed multiple acquisitions in 2025, funded entirely through free cash flow, resulting in no common shareholder dilution [10] - The acquisition of Medsphere Systems expanded CareCloud's reach into the inpatient hospital market and added new software products [11] - The fourth-quarter revenue included approximately $7.2 million related to the Medsphere acquisition [12] AI Initiatives - CareCloud launched an AI Center of Excellence in April 2025, focusing on integrating AI solutions into healthcare workflows [14] - The flagship AI product, stratusAI Desk Agent, was fully released in December 2025, handling various administrative tasks [15] - AI tools are being utilized to improve revenue cycle management operations, aiming for "zero touch claims" with minimal human intervention [17] 2026 Guidance - For 2026, CareCloud guided revenue of $128 million to $130 million and adjusted EBITDA of $29 million to $31 million, reflecting margin expansion [19] - GAAP EPS is expected to be between $0.20 and $0.23, representing an increase of over 100% from 2025 [19] Market Position - CareCloud's healthcare IT solutions are supported by over 25 years of proprietary data, providing a competitive advantage in the industry [21] - The company serves small to mid-size physician groups and specialty clinics across the United States, enhancing operational efficiency through its cloud-based platform [23][24]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow for 2025 reached approximately $20.5 million, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million to $130 million for 2026, with adjusted EBITDA of $29 million to $31 million [15] - The company anticipates GAAP EPS of $0.20 to $0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution, innovation, and creating long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms, enhancing their attractiveness and market position [38][41] Question: What was behind the recent contract wins with new customers? - Management noted the expansion of the sales and marketing team and the focus on cross-selling and upselling existing customers, particularly those acquired through recent transactions [45][46] Question: How should investors think about CareCloud's exposure to AI disruption? - Management emphasized that the company operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing the capital structure, and investing in AI development [73] Question: Who are the company's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape is broader, with some players lacking a vertical approach [75][78]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million [15] - The company anticipates GAAP EPS of $0.20-$0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution and innovation to create long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms to enhance their attractiveness and market position [38][41] Question: What was behind the recent contract wins and future opportunities? - Management noted the expansion of the sales team and the focus on cross-selling additional services to existing clients acquired through recent transactions [45][46] Question: How does CareCloud's exposure to AI disruption compare to being an AI beneficiary? - Management emphasized that CareCloud operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing capital structure, and investing in AI development [73] Question: Who are CareCloud's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape varies depending on the product [75][76]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth, with Q4 revenue of $34.4 million, up nearly 22% year-over-year [6][32] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10, marking the first full year of positive EPS since the 2014 IPO [6][31] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [7][33] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [7][34] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [9][10] - Revenue related to the Medsphere acquisition in Q4 was approximately $7.2 million [32] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment, creating a multi-billion-dollar addressable opportunity in the U.S. [11][12] - The company aims to leverage its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [12] Company Strategy and Development Direction - The 2026 growth strategy focuses on penetrating newly acquired health system customers with RCM and AI products, emphasizing operating leverage from strategic investments [11][14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million and GAAP EPS of $0.20-$0.23 per share, representing over 100% growth from 2025 [14][15] - The company highlighted its strong financial position, with zero drawn on its credit line and a focus on disciplined execution and innovation [15][34] Other Important Information - The company resumed dividends on preferred shares in early 2025 and began paying double dividends on Series B preferred stock starting in 2026 [8][31] - The AI Center of Excellence was launched in April 2025, focusing on building AI solutions that create measurable impact for healthcare providers [17][18] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms, enhancing their attractiveness and market position [39][41] Question: What was behind the recent contract wins and future opportunities? - The company has expanded its sales and marketing team, focusing on cross-selling and upselling to existing customers acquired through recent transactions [45][46] Question: How should investors think about CareCloud's exposure to AI disruption? - Management emphasized that CareCloud operates in a niche healthcare IT market with deep industry moats, making it less vulnerable to generic AI disruptions [54][55] Question: What are the focuses for the use of excess cash flow? - The company aims to use excess cash flow for acquisitions, enhancing capital structure, and investing in AI development [73][74] Question: Who are CareCloud's main competitors? - Competitors include eClinicalWorks, AdvancedMD, and athenahealth in the EHR space, with a wider field in AI solutions [75][76]

Core Insights - CareCloud, Inc. reported strong financial results for the full year and fourth quarter ended December 31, 2025, exceeding revenue guidance and achieving its first full-year positive GAAP EPS since its IPO in 2014 [1][4]. Financial Highlights - Full-year revenue reached $120.5 million, an increase of 8.7% from $110.8 million in FY 2024 [2]. - Fourth-quarter revenue was $34.4 million, up 21.9% from $28.2 million in Q4 2024 [2]. - GAAP net income for FY 2025 was $10.8 million, a 37.5% increase from $7.9 million in FY 2024 [2]. - GAAP EPS for FY 2025 was $0.10, compared to a loss of $0.28 in FY 2024, marking a significant turnaround [2]. - Adjusted EBITDA for FY 2025 was $27.5 million, up 14.5% from $24.1 million in FY 2024 [2]. Strategic Developments - CareCloud entered the inpatient software market through strategic acquisitions, expanding its product portfolio to include inpatient EHR, RCM, analytics, and a top-ranked EDIS platform [5]. - The company launched AI products, including stratusAI Desk Agent, which automates approximately 75% of inbound calls, enhancing operational efficiency [5][6]. - CareCloud fully repaid $9.3 million on its line of credit by year-end, demonstrating strong cash flow generation [5]. Management Commentary - The CEO highlighted that 2025 was a transformative year, with the company proving its business model and achieving significant milestones in revenue and profitability [4]. - The Chief Strategy Officer emphasized the integration of AI and acquisition strategies as a unified growth engine, enhancing the value of acquired platforms [4]. 2026 Outlook - CareCloud projects revenue for FY 2026 to be between $128 million and $132 million, representing a growth of approximately 6-10% over FY 2025 [7]. - Adjusted EBITDA guidance for FY 2026 is set at $29 million to $31 million, indicating a growth of 5-13% from FY 2025 [7]. - GAAP EPS guidance for FY 2026 is expected to be between $0.20 and $0.23, reflecting a 100-130% increase from FY 2025 [7].

Core Insights - The traditional front desk model in healthcare is deemed unsustainable, prompting the need for innovative solutions like AI voice agents [3] - CareCloud is introducing stratusAI Desk Agent, an AI-powered front desk solution aimed at modernizing patient phone access [2] Company Overview - CareCloud is led by Co-CEO Hadi Chaudhry, along with key leaders Aman Haq and Maaz Siddiqui, focusing on AI initiatives and product growth [1] AI Initiatives - Aman Haq has over 5 years of experience in AI-driven product development, previously working at Microsoft as a Senior Product Manager [2] - The company emphasizes the importance of AI in enhancing customer engagement and operational workflows within healthcare [5]

Core Insights - CareCloud has launched stratusAI Desk Agent, an AI-driven phone receptionist aimed at modernizing patient phone interactions and automating call center workflows [1][2][3] Group 1: Product Features and Benefits - stratusAI Desk Agent manages nearly 80% of inbound calls for medical practices, allowing staff to focus on complex patient needs while maintaining service quality [2] - The AI solution provides 24/7 phone access through autonomous, human-like conversations, enhancing patient engagement and operational efficiency [3][4] - It automates various tasks including appointment scheduling, call triage, prescription refill requests, and responses to common patient inquiries [6] Group 2: Market Opportunity - The total addressable market for stratusAI Front Desk in the U.S. is estimated to exceed $4 billion annually, representing significant growth potential in healthcare technology [5] - CareCloud is positioned to lead the transformation in healthcare by automating high-volume call operations, which are critical for patient access and operational efficiency [5] Group 3: Integration and Analytics - stratusAI Desk Agent, when combined with stratusAI Voice Audit, offers end-to-end visibility into the patient phone experience, providing actionable intelligence for administrators [5][7] - The integration allows for in-depth call monitoring, quality scoring, and insights into call volumes and service levels, enhancing operational oversight [7]